Novo... 4202 snoisses cifitneics ADA t

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA). The confere... Stay informed with the latest.
Policy & Regulation
上一篇:Elliott... tsetal isasiD ,desoporp laed p
下一篇:Rangers,... M41$ htrow yldetroper laed rae